Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.



Published on

Published in: Health & Medicine
  • Be the first to comment


  1. 1. Alpha-Adrenergic Blockers Dr. Hiwa K. Saaed Ph.D. Pharmacology & Toxicology
  2. 2. Receptor Tissues Response α1 Eye-radial (dilatory) muscle Contacts (mydriasis) Most vascular smooth muscle -Arterioles (skin, viscera) -veins Contraction ↑TPR→↑ diastolic pressure ↑afterload ↑ venous return→↑ preload Bladder trigone and sphincter Contraction→urinary retention Male sex organs Vas deferens→ ejaculation Liver (in some species, rat ) Stimulate glycogenolysis Kidney ↓ rennin release Pilomotor smooth muscle Contraction (erect hair)
  3. 3. Receptor tissue Response α 2 Adrenergic & cholinergic Prejunctional nerve terminals ↓ transmitter release and NE synthesis Platelets Stimulate Aggregation Pancreas (β cells) Inhibit insulin release Some vascular smooth muscle Contracts Fat cells Inhibits lipolysis Medullary vasomotor center ↓sympathetic outflow → CO & vasodilation→↓ BP
  4. 4. Localization of 1-Adrenergic Receptors
  5. 5.  Like the agonists, the adrenergic antagonists are classified according to their relative affinities for α1 or α2 receptors .  Drugs that block α-adrenoceptors profoundly affect blood pressure, resulting in decreased peripheral vascular resistance.  Because normal sympathetic control of the vasculature occurs in large part through agonist actions on α-adrenergic receptors  This induces a reflex tachycardia resulting from the lowered blood pressure. Alpha-Adrenergic Blockers
  6. 6. Alpha-Adrenergic Blockers Classification I. Type of blockade 1. Irreversible (non-competitive) : Phenoxybenzamine; slow onset and long duration. 2. Reversible (competitive): All the rest II. Selectivity: α1 or α2 receptors . -Nonselective: Phenoxybenzamine and phentolamine -Selective: 1. alpha-1 selective: Prazosin, terazosin, others 2. alpha-2 selective: Yohimbine 3. alpha/beta blockers: Labetalol -Others: phenothiazines, haloperidol, tricyclic antidepressants trazodone
  7. 7. α Antagonists Receptor Affinity Prazosin, terazosin, doxazosin α1>>>>α2 Phenoxybenzamine α1>α2 Phentolamine α1=α2 Rauwolscine, yohimbine, tolazoline α2>α1 Mixed antagonists Labetalol, carvedilol β1=β2≥α1>α2
  8. 8. Alpha-Adrenergic Blockers Nonselective – Phenoxybenzamine (3-4 days) Selective • Short-acting selective 1-blocker – Prazosin t1/2 3 hrs, Alfuzosin t1/2 5 hrs • Long-acting selective 1-blockers – Terazosin t1/2 9-12 hrs – Doxazosin t1/2 22 hrs • Long-acting selective 1A-subtype – Tamsulosin t1/2 9-15 hrs
  9. 9. Pharmacological Effects - Phenoxybenzamine 1. Cardiovascular system • ↓PR: ↓ Blood pressure: reflex tachycardia: • Furthermore, the ability to block presynaptic inhibitory α2-receptors in the heart will result in more norepinephrine release, which stimulates β- receptors on the heart to increase cardiac output. • It reduces BP when sympathetic tone is high upright posture, reduced blood volume
  10. 10. Adrenergic System - Antagonists
  11. 11. Epinephrine reversal: • All α-adrenergic blockers reverse the α-agonist actions of epinephrine. the vasoconstrictive action of epinephrine is interrupted, but vasodilation of other vascular beds caused by stimulation of β2 receptors is not blocked. • Therefore, the systemic blood pressure decreases in response to epinephrine given in the presence of phenoxybenzamine. ….Why? • The actions of norepinephrine are not reversed but are diminished, …why?
  12. 12. Pharmacological Effects – Phenoxybenzamine 2. Eye – miosis 3. Nasal stuffiness 4. GI tract – Increased motility 5. Urinary bladder – decreased tone in sphincter 6. Metabolic effects – increased insulin secretion 7. It also blocks histamine, serotonin and cholinergic receptors
  13. 13. Clinical uses - Phenoxybenzamine 1. Pheochromocytoma: a catecholamine- secreting tumor of cells derived from the adrenal medulla 2. Raynaud; peripheral vascular disease 3. Autonomic hyperreflexia which predisposes paraplegics to strokes 4. BPH
  14. 14. Adverse effects Phenoxybenzamine • Postural hypotension • Tachycardia it is contraindicated in patients with decreased coronary perfusion. • Sedation, fatigue • Nasal stuffiness • Miosis • Impotence (inhibits ejaculation) • Exercise care in hypovolemic patients.
  15. 15. Imidazoline derivatives – phentolamine (5-7hr) produces a competitive block of α1 and α2- receptors. 1. Block serotonin receptors 2. Stimulate H1 & H2 3. Stimulate M1; Parasympathomimetic • Increased gastric motility & acid secretion • Increased secretion from exocrine glands, such as salivary, sweat, lacrimal, pancreatic • Cardiac stimulation reflex and direct!! • it can be injected intracavernosally to produce vasodilation of penile arteries (rarely used)
  16. 16. Alpha-1 selective blockers Prazosin, terazosin, doxazosin, alfuzosin, and tamsulosin • the first three drugs are useful in the treatment of hypertension. • Alfuzosin & Tamsulosin are indicated for the treatment of benign prostatic hypertrophy • Prazosin (t1/2 3hrs): No significant tachycardia Used in CHF and in hypertension but tolerance develops with time, may be due to fluid retention. • Adverse effects: First dose phenomenon. • Favorable effect on plasma lipids: increase HDL/LDL ratio • Terazosin (t1/2 9-12 hrs)
  17. 17. Other α -adrenoceptor antagonists • Indoramin: antihypertensive. • Urapidil is an α1 antagonist (its primary effect) that also has weak α2-agonist and 5-HT1A-agonist actions and weak antagonist action at β1 receptors. It is used in Europe as an antihypertensive agent and for BPH. • Labetalol has both α1-selective and β-antagonistic effects. • Neuroleptic drugs such as chlorpromazine and haloperidol are potent dopamine receptor antagonists but are also antagonists at α-receptors. • Antidepressant: trazodone block α1 receptors.
  18. 18. 2 - selective antagonists Yohimbine Chief active compound in Pausinystalia yohimbine (bark), Effects opposite of Clonidine Enters CNS => increased sympathetic output => increased HR, BP, can cause severe tremors Ingredient in many weight loss products Enhances sexual activity – aphrodisiac Blocks other receptors: serotonin, dopamine, Increases ADH release Experimental uses in Treatment of : 1. Raynaud's phenomenon to inhibit smooth muscle contraction, 2. type 2 diabetes (α2 receptors inhibit insulin secretion), 3. depression.
  19. 19. Therapeutic Uses of Alpha-Adrenergic Blockers • Hypertension - alpha-1 selective • Pheochromocytoma • Peripheral vascular disease – Raynaud’s • Local Vasoconstrictor Excess • Benign prostatic hyperplasia • Erectile Dysfunction: Yohimbine or intracavernous phentolamine + papaverine